Epidemiology of infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp.:: a nested case-control study from a tertiary hospital in London

被引:49
作者
Skippen, I.
Shemko, M.
Turton, J.
Kaufmann, M. E.
Palmer, C.
Shetty, N.
机构
[1] UCL Hosp, HPA Collaborating Ctr, NHS Trust, Dept Clin Microbiol, London W1T 4JF, England
[2] UCL Hosp, NHS Trust, HPA Collaborating Ctr, London, England
[3] Ctr Infect, HPA, Lab Healthcare Associated Infect, London, England
关键词
ESBL; epidemiology; hospital-acquired infection;
D O I
10.1016/j.jhin.2006.05.010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Information on risk factors for acquisition of extended-spectrum beta-lactamase (ESBL)-producing organisms and their outcomes in patients with invasive infections is scant. The objectives of this study were to evaluate risk factors and all-cause mortality associated with infection due to ESBL-producing organisms using a nested case-control design, and to document transmission within a hospital employing molecular and conventional epidemiological methods. From December 2003 to April 2005, 50 patients with bloodstream infections (BSIs) due to ESBL-producing E. coli and Klebsiella spp. were recruited. Controls (N = 50) were chosen, within the same period, from patients with non-ESBL-producing BSIs by simple random sampling; account was taken of potential confounding factors. Cases and controls were followed-up until November 2005, and outcomes were recorded as discharged or deceased. Molecular methods, supported by conventional epidemiology, were used to study the transmission of organisms. Logistic regression analyses showed prior B-lactam antibiotics [odds ratio (OR) 11.57; 95% confidence intervals (CI) 2.31-51.15; P = 0.003], hospital. stay > 15 days (OR 2.63; 95% CI 1.01-6.89; P = 0.04) and prior admission to the intensive care unit (OR 13.98; 95% CI 1.88-19.15; P = 0.006) to be independent risk factors for the acquisition of ESBL-producing organisms. In the first 15 days of follow-up, a significant proportion of patients with ESBL-producing organisms died; however, there was no difference in mortality between cases and controls at the end of the follow-up period. Molecular epidemiology identified five clusters amongst the ESBL-producing isolates. Conventional epidemiological analyses supported the evidence of transmission in three of these clusters. (c) 2006 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 18 条
[1]   Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum β-lactamases [J].
Ali Shah, A ;
Hasan, F ;
Ahmed, S ;
Hameed, A .
RESEARCH IN MICROBIOLOGY, 2004, 155 (06) :409-421
[2]  
BHAVNANI SM, 2006, DIAGN MICROBIOL INFE, V16, P16
[3]   Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients [J].
Colodner, R ;
Rock, W ;
Chazan, B ;
Keller, N ;
Guy, N ;
Sakran, W ;
Raz, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (03) :163-167
[4]   Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection:: risk factors and clinical outcome [J].
Du, B ;
Long, Y ;
Liu, HZ ;
Chen, DC ;
Liu, DW ;
Xu, YC ;
Xie, XL .
INTENSIVE CARE MEDICINE, 2002, 28 (12) :1718-1723
[5]   Prevalence and antimicrobial susceptibility data for extended-spectrum β-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004) [J].
Goossens, H ;
Grabein, B .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 53 (04) :257-264
[6]   Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes [J].
Ho, PL ;
Chan, WM ;
Tsang, KWT ;
Wong, SSY ;
Young, K .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2002, 34 (08) :567-573
[7]   Mechanisms of disease:: The new β-lactamases [J].
Jacoby, GA ;
Munoz-Price, LS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04) :380-391
[8]   Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy [J].
Kang, CI ;
Kim, SH ;
Park, WB ;
Lee, KD ;
Kim, HB ;
Kim, EC ;
Oh, MD ;
Choe, KW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) :4574-4581
[9]   Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae [J].
Kang, CI ;
Kim, SH ;
Kim, DM ;
Park, WB ;
Lee, KD ;
Kim, HB ;
Oh, MD ;
Min, EC ;
Choe, KW .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (10) :860-867
[10]   CTX-M: changing the face of ESBLs in the UK [J].
Livermore, DM ;
Hawkey, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (03) :451-454